Russia vaccine Sputnik V on to trial

DCGI gives nod to clinical trials of Russia’s coronavirus vaccine Sputnik V

LOGODrugs Controller General of India, DCGI has allowed Dr. Reddy’s Laboratories and Russian Direct Investment Fund (RDIF) to conduct phase 2 and 3 clinical human trials of Sputnik 5 COVID vaccine in the country. 

Sputnik 5 Vaccine has been developed in Russia where it has also undergone phase 1 and 2 clinical trials. The clinical trial in India will be a multi-center and randomised controlled study which will primarily focus on safety and immunogenicity study. 

Earlier last month, Dr. Reddy’s and RDIF entered into partnership to conduct clinical trials of Sputnik 5 vaccine and its distribution in the country.
The vaccine is currently undergoing phase 3 clinical trials in Russia along with simultaneous trails in UAE.

Published by Naresh Sagar

Mentor MSME, Motivator, Media Event Org, Management fiscal & Water management.Social Media branding,Internet broadcasters,Propunder of Indian Philosophy

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: